-+ 0.00%
-+ 0.00%
-+ 0.00%

IRONWOOD PHARMACEUTICALS INC: LINZESS IS CONTRAINDICATED IN PATIENTS WITH KNOWN OR SUSPECTED MECHANICAL GASTROINTESTINAL OBSTRUCTION

Reuters·05/27/2026 14:00:01

Please log in to view news